Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026)
Valneva SE (VALN) posted quarterly Depreciation & Amortization - Total of $4.8 million for Q1 2026, little changed year-on-year from $4.8 million in Q1 2025, and down 2.33% on a QoQ basis from $4.9 million in Q4 2025.
Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Depreciation & Amortization - Total for 5 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.
- Quarterly Depreciation & Amortization - Total changed 0.0% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 million (up 9.74% YoY) and the FY2025 annual result came in at $19.2 million, up 14.97% from the prior year.
- Depreciation & Amortization - Total fell to $4.8 million in Q1 2026 per VALN's latest filing, from $4.9 million in the prior quarter.
- Over the last five years, Depreciation & Amortization - Total for VALN reached as high as $12.0 billion in Q3 2022 and fell as low as -$12.0 billion in Q4 2022.
- A 5-year average of $4.1 million and a median of $4.2 million in 2024 frame the typical range for Depreciation & Amortization - Total.
- The largest YoY upside for Depreciation & Amortization - Total was 100.03% in 2023 against a maximum downside of 99.97% in 2023.
- Year by year, Depreciation & Amortization - Total stood at -$12.0 billion in 2022, then soared by 100.03% to $3.9 million in 2023, then grew by 17.65% to $4.6 million in 2024, then climbed by 7.5% to $4.9 million in 2025, then dropped by 2.33% to $4.8 million in 2026.
- According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $4.8 million, $4.9 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Sep 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 2.96 Mn |
| Dec 31, 2022 | -12.02 Bn |
| Sep 30, 2022 | 12.03 Bn |